BCI Pharma is a startup based in France, most recent round Series A, 1 tracked investor.
Based in France, BCI Pharma is a startup founded in 2017. Its most recent tracked round is Series A. Brouky records 1 investor associated with the company.
BCI Pharma is a clinical-stage biotechnology company developing innovative small molecule therapies for severe inflammatory diseases, particularly those affecting the central nervous system. Their lead program targets the NLRP3 inflammasome pathway.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.